hepatocyte hypertrophy
Ward JD, Barnes CG, Fisher DJ, Jessop JD, Baker RW: Improvement in nerve conduction following treatment in newly diagnosed diabetics
By: Matt Weik, BS, CSCS, CPT, CSN References Virmani, Mohamed Ashraf, and Maria Cirulli
Bridons research contributions include: Development of Drug Affinity Complex (DAC) technology for albumin binding and peptide half-life extension Identification and characterization of CJC-1295 as a long-lasting GRF analog with sustained growth hormone-releasing properties Pioneering work on maleimido-derivatized GHRH analogs and their bioconjugation to serum albumin Demonstration of 4-fold increase in growth hormone area-under-curve with optimized CJC-1295 formulation versus native GHRH Extensive in vitro and in vivo pharmacological characterization in rat and human models His 2005 publication in Endocrinology titled Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog remains the foundational reference for CJC-1295 research, establishing the peptides mechanism of action and pharmacokinetic profile that enabled subsequent clinical investigation
This peptide combination is capable of increasing lean muscle mass, improving sleep quality and promote recovery, enhance skin health, appearance, increase libido, burning visceral and abdominal fat
Hepatology 65, 189201
